1257432-06-6

Basic information

• Product Name: N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoroMethyl)pyridin-2-aMine
• Synonyms: N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoroMethyl)pyridin-2-aMine
• CAS NO: 1257432-06-6
• Molecular Formula: C14H20BF3N2O2
• Molecular Weight: 316.1270096
• Mol File: 1257432-06-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoroMethyl)pyridin-2-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoroMethyl)pyridin-2-aMine(1257432-06-6)
• EPA Substance Registry System: N-ethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoroMethyl)pyridin-2-aMine(1257432-06-6)

Safety Data

• Hazardous Substances Data: 1257432-06-6(Hazardous Substances Data)

Relevant articles and documents

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.